Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Sanofi

Tracked across 62 events · 776 articles · First seen Dec 05, 2025 · Last active Sep 22, 2026

Sentiment
11
Attention
7
Events
62
Relationships
24
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: Sanofi announced positive Phase 2 clinical trial results for its drug lunsekimig in respiratory diseases, which could lead to new treatment options and future revenue streams.
Apr 07, 2026 · 6 articles
4 75
Business
Impact: Sanofi, in collaboration with Regeneron Pharmaceuticals, developed Dupixent and received International — European Commission approval for its use in treating chronic spontaneous urticaria in young children, which is expected to boost its market position and revenue.
Apr 13, 2026 · 8 articles
2 10
Business
Impact: Sanofi is extending its commitment to improving lives beyond healthcare through its foundation's strengthened focus on children and young people, which could enhance its corporate social responsibility image.
Jun 25, 2026 · 6 articles
4 -30
Regulatory
Impact: Sanofi is under formal antitrust investigation by the International — European Commission for allegedly disparaging a rival flu vaccine, which could lead to penalties and reputational damage.
Jun 26, 2026 · 6 articles
4 70
Business
Impact: Sanofi has received priority review for its drug venglustat, which could significantly expand its portfolio in lysosomal storage diseases and provide a new revenue stream if approved.
May 28, 2026 · 6 articles
4 70
Business
Impact: Sanofi is adopting Snowflake Inc.'s AI Data Cloud and Elementum's AI solutions to accelerate drug development, improve sales operations, and become an AI-powered biopharma company. This move is expected to enhance its operational efficiency and innovation capabilities.
Jun 02, 2026 · 6 articles
2 20
Business
Impact: Sanofi launched its 2026 global employee stock purchase plan, Action 2026, to involve employees in the company's growth and results. This initiative aims to strengthen employee commitment and ownership in the company.
Jun 04, 2026 · 8 articles
0 0
Business
Impact: Sanofi is the subject of the report, disclosing its half-year financial results and regulatory filings.
Jul 30, 2026 · 13 articles
2 20
Business
Sanofi inaugurated the Charles Best Building, a new flu vaccine manufacturing facility on its 52-acre Canada — Toronto campus, on September 16, 2026. The project represents a $925 million CAD investment, the single-largest biomanufacturing investment…
Impact: Sanofi is the central actor, inaugurating the $925 million Charles Best Building and expanding its Canadian vaccine manufacturing capacity. The facility supports future Fluzone High-Dose production and pandemic preparedness, a modest positive for its long-term growth outlook.
Sep 16, 2026 · 6 articles
2 20
Business
Impact: Sanofi expands its collaboration with Aqemia by nominating a new therapeutic target, demonstrating continued investment in AI-driven drug discovery, though the financial commitment is small relative to its overall R&D budget.
Jul 17, 2026 · 6 articles
2 40
Business
Impact: Sanofi is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
4 20
Domestic
Impact: Sanofi is a major insulin maker that has moved to cut the cost of insulin and offers a savings program for people without health insurance.
Apr 02, 2026 · 6 articles
4 60
Business
Impact: Sanofi participated in a concurrent private placement, purchasing 500,000 shares for $7.5 million, and has a prior $1.5 billion research collaboration with Scribe. This deepens Sanofi's strategic involvement in gene editing and cardiovascular therapies.
Jul 06, 2026 · 25 articles
2 5
Regulatory
Chairs of nine European pharmaceutical companies published an open letter on their corporate websites on September 22, 2026, calling on the European Union and its member states to boost investment in the region's drug industry.…
Impact: A signatory of the open letter calling on the European Union to boost pharmaceutical investment. The appeal reflects its concern about Europe lagging the United States and China in drug research and trials.
Sep 22, 2026 · 6 articles
2 50
Business
Impact: Sanofi is a key partner, having licensed rovadicitinib from Sino Biopharmaceutical in a deal valued up to US$1.53 billion. This adds a promising asset to Sanofi's pipeline, potentially enhancing its respiratory and immunology portfolio.
Jul 20, 2026 · 6 articles
1 5
Business
The fifth edition of the PBC (Philanthropy for Better Cities) forum, themed 'Leaping for Impact', will be held at the West Kowloon Cultural District in Hong Kong from 7 to 8 September 2026. Convened by…
Impact: Sanofi, through its foundation, participates in the forum, aligning with its corporate social responsibility and potentially enhancing its brand.
Jul 20, 2026 · 7 articles
2 10
Domestic
Impact: Partners with Novavax on the non-mRNA COVID-19 vaccine, gaining from potential increased demand.
Sep 02, 2026 · 20 articles
4 10
International
General Secretary of the Cuba — Communist Party of Cuba Central Committee and President Tô Lâm is making an official visit to France and attending the International Space Summit in Paris from September 10-12, 2026,…
Impact: Sanofi is involved in a planned large-scale vaccine production project with Vietnam Vaccine Joint Stock Company in Ho Chi Minh City, which could expand its market presence in Vietnam.
Sep 05, 2026 · 12 articles
4 50
Regulatory
Impact: Sanofi is co-developing the GBP410 pneumococcal vaccine candidate with Altor BioScience. The financing secured by Altor BioScience will indirectly support the joint development efforts.
May 29, 2026 · 6 articles
4 -20
Business
Impact: Sanofi's Lantus faces new competition from Awiqli, which offers less frequent dosing and lower cost per unit.
Jul 09, 2026 · 21 articles
1 10
Business
Impact: Sanofi participated in the symposium, reflecting its interest in sustainable manufacturing technologies.
Jul 20, 2026 · 6 articles
3 50
Tech
Impact: Major contributing member; contributes data and expertise.
Jul 13, 2026 · 6 articles
7 -20
Regulatory
Impact: Sanofi's high-dose flu vaccine served as a comparator in trials; the new mRNA vaccine may compete with its products.
Aug 05, 2026 · 105 articles
4 10
Tech
Impact: Sanofi is an early adopter of YesWeHack's Agentic Pentest, suggesting a proactive approach to enhancing their cybersecurity defenses.
Jun 25, 2026 · 6 articles
6 -30
Regulatory
Impact: Co-marketer of Praluent; faces similar competitive pressure.
Jul 16, 2026 · 93 articles
2 10
Tech
Impact: Sanofi's head of exploratory biomarkers, Zhang Rui, provided a positive testimonial about the panel's utility in drug development, indicating potential collaboration or adoption.
Jul 28, 2026 · 6 articles
0 0
Business
Impact: Sanofi piloted the technology in a program for moderate-to-severe asthma, demonstrating real-world application. This event does not affect Sanofi directly.
Aug 13, 2026 · 6 articles
1 0
Business
Impact: Sanofi conducted a pilot with the Trustr technology in moderate-to-severe asthma, validating its potential. This event does not directly affect Sanofi's operations or financials.
Aug 17, 2026 · 6 articles
4 40
Regulatory
Impact: Already a customer of Pulse's manufacturing, the approval may strengthen their supply relationship.
Aug 20, 2026 · 6 articles
4 -10
Business
Impact: Sanofi's Dupixent competes with Tezspire in severe asthma and potentially in eosinophilic esophagitis. Tezspire's success could increase competitive pressure on Dupixent.
Aug 27, 2026 · 6 articles
+ 32 more events View on Dashboard
ERGEN INTELLIGENCE
Track Sanofi live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.